All View

Product Information BR-1302_PI_01.pdf
Registration Number BR-1302
Generic Name Daratumumab
Brand Name Darzalex
Dosage Strength 20 mg/mL
Dosage Form Concentrate For Solution For Infusion (Iv)
Classification Prescription Drug (Rx)
Packaging Type I Glass vial with an elastomeric Closure and an aluminum seal with a flip-off cap x 5mL (Box of 1's)
Pharmacologic Category -
Manufacturer Cilag AG
Country of Origin Switzerland
Importer Johnson & Johnson (Phils.), Inc.
Application Type -
Issuance Date 01 August 2019
Expiry Date 01 August 2024